Literature DB >> 11677979

Nodular regenerative hyperplasia of the liver. A review of 14 cases.

M Arvanitaki1, M Adler.   

Abstract

BACKGROUND/AIMS: Nodular regenerative hyperplasia of the liver, is a noncirrhotic liver disease, characterized by nodules in the hepatic parenchyma, which clinically presents primarily with manifestations of portal hypertension. The aims of this study are i) to review the clinical, histological and diagnostic aspects of 14 documented cases of NRHL, and ii) to assess the evolution and management of this condition in the cases reviewed.
METHODOLOGY: The diagnosis of nodular regenerative hyperplasia of the liver was based on liver biopsy in all cases. Imaging studies (ultrasonography, computed tomography scan and magnetic resonance imaging scan) were performed as part of the diagnostic evaluation. Clinical manifestations and biochemical tests were recorded at the time of diagnosis. Management and prognosis were also reviewed.
RESULTS: The most common clinical manifestations were those of portal hypertension, namely splenomegaly, esophageal varices and variceal bleeding. The histological findings were nodules in the hepatic parenchyma, the typical histologic feature of nodular regenerative hyperplasia of the liver, with mild periportal fibrosis and intraportal lymphocytic infiltration. Biochemical tests showed normal synthetic liver function, as evidenced by normal serum albumin, bilirubin and prothrombin time. Elevation of gamma-glutamyl transpeptidase and alkaline phosphatase due to cholestasis was noted. Management was directed to portal hypertension and variceal bleeding, with beta-blockers, sclerotherapy, mesenteric-caval shunt and transjugular intrahepatic portosystemic shunt with satisfactory results.
CONCLUSIONS: Nodular regenerative hyperplasia of the liver is an uncommon condition but it should be considered in patients with unexplained portal hypertension and distinguished from liver cirrhosis, in view of the differences in the natural history and prognosis. Liver biopsy confirms the diagnosis. Management is directed primarily to portal hypertension and variceal bleeding, which is the main source of mortality. Liver failure is uncommon due to satisfactory preservation of liver function.

Entities:  

Mesh:

Year:  2001        PMID: 11677979

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  11 in total

Review 1.  [Nodular lesions of liver parenchyma caused by pathological vascularisation/perfusion].

Authors:  H-P Fischer; H Zhou
Journal:  Pathologe       Date:  2006-07       Impact factor: 1.011

2.  Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine.

Authors:  G Vernier-Massouille; J Cosnes; M Lemann; P Marteau; W Reinisch; D Laharie; G Cadiot; Y Bouhnik; M De Vos; A Boureille; B Duclos; P Seksik; J-Y Mary; J-F Colombel
Journal:  Gut       Date:  2007-05-15       Impact factor: 23.059

Review 3.  Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension.

Authors:  Marek Hartleb; Krzysztof Gutkowski; Piotr Milkiewicz
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

4.  Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity.

Authors:  Christopher Koh; Sasan Sakiani; Pallavi Surana; Xiongce Zhao; Jason Eccleston; David E Kleiner; David Herion; T Jake Liang; Jay H Hoofnagle; Milica Chernick; Theo Heller
Journal:  Hepatology       Date:  2017-06-26       Impact factor: 17.425

5.  Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units.

Authors:  Berrie Meijer; Melek Simsek; Hans Blokzijl; Robert A de Man; Minneke J Coenraad; Gerard Dijkstra; Carin Mj van Nieuwkerk; Chris Jj Mulder; Nanne Kh de Boer
Journal:  United European Gastroenterol J       Date:  2016-11-16       Impact factor: 4.623

6.  Diagnosing regenerative nodular hyperplasia, the "great masquerader" of liver tumors.

Authors:  Jason M Foster; Alan Litwin; John F Gibbs; Marilyn Intengen; Boris W Kuvshinoff
Journal:  J Gastrointest Surg       Date:  2006-05       Impact factor: 3.452

Review 7.  Radiological and histopathological manifestations of hepatocellular nodular lesions concomitant with various congenital and acquired hepatic hemodynamic abnormalities.

Authors:  Satoshi Kobayashi; Osamu Matsui; Toshifumi Gabata; Junichiro Sanada; Wataru Koda; Tetsuya Minami; Yasuji Ryu
Journal:  Jpn J Radiol       Date:  2009-03-12       Impact factor: 2.374

8.  Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia.

Authors:  C Ward; M Lucas; J Piris; J Collier; H Chapel
Journal:  Clin Exp Immunol       Date:  2008-07-18       Impact factor: 4.330

9.  Solid focal liver lesions: dynamic and late enhancement patterns with the dual phase contrast agent gadobenate dimeglumine.

Authors:  Luigi Grazioli; Maria Pia Bondioni; Niccolò Faccioli; Sebastiana Gambarini; Rita Tinti; Günther Schneider; Miles Kirchin
Journal:  J Gastrointest Cancer       Date:  2010-12

10.  Massive right-sided Bochdalek hernia with two unusual findings: a case report.

Authors:  Subrato J Deb
Journal:  J Med Case Rep       Date:  2011-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.